Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 4,511 | 5,785 | 5,208 | 4,382 | 5,533 |
| Gross Profit | 4,511 | 5,785 | 5,208 | 4,382 | 5,533 |
| Operating Expenses | 34,481 | 40,218 | 29,350 | 27,516 | 27,510 |
| Operating Income | -29,970 | -34,433 | -24,142 | -23,134 | -21,977 |
| Other Income | 1,193 | 1,261 | 947 | 1,089 | 1,200 |
| Pre-tax Income | -28,777 | -33,172 | -23,195 | -22,045 | -20,777 |
| Income Tax | -166 | -330 | -235 | -85 | -125 |
| Net Income Continuous | -28,611 | -32,842 | -22,960 | -21,960 | -20,652 |
| Net Income | $-28,611 | $-32,842 | $-22,960 | $-21,960 | $-20,652 |
| EPS Basic Total Ops | -21.97 | -26.65 | -20.89 | -20.17 | -18.73 |
| EPS Basic Continuous Ops | -22.45 | -26.57 | -20.77 | -20.00 | -18.83 |
| EPS Diluted Total Ops | -21.97 | -26.65 | -20.89 | -20.17 | -18.73 |
| EPS Diluted Continuous Ops | -22.45 | -26.57 | -20.77 | -20.00 | -18.83 |
| EBITDA(a) | $-29,979 | $-34,596 | $-24,269 | $-23,417 | $-22,568 |